Literature DB >> 2317950

Human milk contains proteins that stimulate and suppress T lymphocyte proliferation.

L Mincheva-Nilsson1, M L Hammarström, P Juto, S Hammarström.   

Abstract

The modulatory effect of human milk proteins from colostrum and late milk on the proliferative response of human T lymphocytes activated by mitogens (OKT3 and leucoagglutinin from Phaseolus vulgaris) and alloantigens was studied. High concentrations (10-100 micrograms/ml) of crude colostral milk proteins had an inhibitory effect on T cell growth while low concentrations (0.1-1 microgram/ml) enhanced T cells growth. In contrast, proteins from late milk did not inhibit T lymphocyte proliferation while the enhancing effect was retained. Colostrum was fractionated by ammonium sulphate precipitation and gel filtration on sepharose 6B. The inhibitory activity was recovered in a protein fraction containing lactoferrin as its major component. Lactoferrin was, however, not responsible for the observed inhibition. On the contrary, lactoferrin in most cases augmented the proliferative response induced by polyclonal activators. The inhibitory activity was found to bind concanavalin A-sepharose suggesting an association with glycoprotein. Inhibitory fractions contained glycoproteins of the following molecular sizes 26, 74/76 (doublet), 84, 145 and 160 kD under reducing conditions. The inhibitory effect appeared to be lymphocyte specific since the active fraction did not inhibit the growth of tissue culture cells (HeLa cells and human fibroblasts) or bacteria. Furthermore, the fraction was not toxic for lymphocytes. The inhibitory colostrum factor may prevent the newborn from overreacting immunologically against the environmental antigens encountered at birth.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317950      PMCID: PMC1534957          DOI: 10.1111/j.1365-2249.1990.tb08113.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  16 in total

1.  Exocrine pancreas function in premature and full term neonates.

Authors:  G Zoppi; G Andreotti; F Pajno-Ferrara; D M Njai; D Gaburro
Journal:  Pediatr Res       Date:  1972-12       Impact factor: 3.756

2.  Ontogeny of orally induced tolerance to soluble proteins in mice. I. Priming and tolerance in newborns.

Authors:  D G Hanson
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

3.  Immune responses to fed protein antigens in mice. 3. Systemic tolerance or priming is related to age at which antigen is first encountered.

Authors:  S Strobel; A Ferguson
Journal:  Pediatr Res       Date:  1984-07       Impact factor: 3.756

4.  Detection of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG), an immunosuppressive agent, in IgA producing plasma cells and in body secretions.

Authors:  C H Horne; S S Armstrong; A W Thomson; W D Thompson
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

5.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  Inhibition of the pokeweed mitogen-induced response of normal peripheral blood lymphocytes by humoral components of colostrum.

Authors:  S S Crago; R Kulhavy; S J Prince; J Mestecky
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

7.  Active suppression of host-vs graft reaction in pregnant mice. IX. Soluble suppressor activity obtained from allopregnant mouse decidua that blocks the cytolytic effector response to IL-2 is related to transforming growth factor-beta.

Authors:  D A Clark; M Falbo; R B Rowley; D Banwatt; J Stedronska-Clark
Journal:  J Immunol       Date:  1988-12-01       Impact factor: 5.422

8.  A colostral protein that induces the growth and differentiation of resting B lymphocytes.

Authors:  M H Julius; M Janusz; J Lisowski
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

Review 9.  Protective factors in milk and the development of the immune system.

Authors:  L A Hanson; S Ahlstedt; B Andersson; B Carlsson; S P Fällström; L Mellander; O Porras; T Söderström; C S Edén
Journal:  Pediatrics       Date:  1985-01       Impact factor: 7.124

10.  Biochemistry and physiological function of human milk proteins.

Authors:  B Lönnerdal
Journal:  Am J Clin Nutr       Date:  1985-12       Impact factor: 7.045

View more
  7 in total

1.  Whey: a by-product for eucaryotic cell cryopreservation.

Authors:  J Capiaumont; C Jacob; C Frossi; P Nabet; B Dousset
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000 Nov-Dec       Impact factor: 2.416

Review 2.  Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

Review 3.  Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies.

Authors:  A K Akobeng; A V Ramanan; I Buchan; R F Heller
Journal:  Arch Dis Child       Date:  2005-11-15       Impact factor: 3.791

4.  Apoptosis induced by a human milk protein.

Authors:  A Håkansson; B Zhivotovsky; S Orrenius; H Sabharwal; C Svanborg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

5.  Effect of human colostrum on interleukin-2 production and natural killer cell activity.

Authors:  L Sirota; R Straussberg; I Notti; H Bessler
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-09       Impact factor: 5.747

6.  Human colostrum contains an activity that inhibits the production of IL-2.

Authors:  J W Hooton; H F Pabst; D W Spady; V Paetkau
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

7.  Early Infant Feeding Practices May Influence the Onset of Symptomatic Celiac Disease.

Authors:  Shailja Vajpayee; Shiv Dayal Sharma; Rajkumar Gupta; Alok Goyal; Aakash Sharma
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2016-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.